Who may participate

This study is seeking healthy male and female participants. Participants must be healthy, meaning they will not have the condition for which this treatment is being developed and are in overall good health. 

You may not take part in this study if:
 

  • You are under the age of 18
  • You have a Body Mass Index outside of 16 - 32 kg/m2 or your weight is equal to or less than 50 kg.


There are other requirements for participation in this study. Please read attentively the Informed Consent Document (ICD), more explanation will be provided by the study staff during the screening process.

Condition

Healthy

Age

18+

Sex

Male/female

Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

What to expect

If this study may be a fit for you, you’ll be invited to a screening visit at our facility in Brussels, Belgium.

The study is planned to last for approximately 10 weeks.
 

  •  A screening examination.
  • You will stay in the PCRU for 4 consecutive treatment periods, comprised of a total of 10 days and 9 nights.

You will be screened within 28 days prior to the first dose of study intervention.


Throughout the study, staff will closely monitor your health status and collect data.


You will not personally derive any benefit from your participation in this study, but the results obtained could be very important for the development of medicines and treatments which will benefit other people.

View the calendar

How long is the study?

Approximately 10 weeks

Compensation

Up to € 2.640, plus travel fees